Seclidemstat mesylate Catalog No.:M33533-2 14 and 21 after tumor

14 and 21 after tumor cell inoculation

Dicloxacillin exhibits therapeutic activity in murine peritonitis-sepsis model and all the mice are survivied

InChi: InChI=1S/C21H22O5/c1-4-6-7-9-17(22)18-16-11-13-10-14(8-5-2)25-12-15(13)19(23)21(16

Formula: C10H15N5O5

Seclidemstat mesylate Catalog No.:M33533-2 14 and 21 after tumorSeclidemstat (SP 2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor (Ki=31 nM, IC50=13 nM). Seclidemstat mesylate promotes antitumor immunity in switch sucrose nonfermentable (SWI SNF) complex mutated ovarian cancer, as well as inhibit virus production, viral DNA replication, and late gene expression. Seclidemstat mesylate can be used for the research of Ewing Sarcoma. Product information CAS Number: 2044953 70 8 Molecular